Zimmer Biomet Receives FDA Clearance for Enhanced ROSA Knee Robotic System

Zimmer Biomet Holdings Inc. has received U.S. FDA 510(k) clearance for ROSA® Knee with OptimiZe™, an enhanced version of its robotic-assisted knee replacement system. The newly cleared technology offers surgeons a more personalized and efficient surgical planning experience, featuring customizable workflows, improved accuracy, and integration with ZBEdge® Analytics for data-driven decision-making. Commercial availability in the U.S. is expected in the first quarter of 2026. No other organizations were mentioned as recipients of this clearance. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zimmer Biomet Holdings Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: DE24216) on November 14, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)